US Patent Issued to ACCELERON PHARMA on March 24 for "Actrii proteins and use in treating post-capillary pulmonary hypertension" (Massachusetts Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,906, issued on March 24, was assigned to ACCELERON PHARMA INC. (Cambridge, Mass.).

"Actrii proteins and use in treating post-capillary pulmonary hypertension" was invented by Gang Li (Cambridge, Mass.), Ravindra Kumar (Cambridge, Mass.), Jonathan Toshi Lu (Cambridge, Mass.), Sachindra Joshi (Cambridge, Mass.) and Patrick Andre (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In some aspects, the disclosure relates to compositions and methods comprising ActRII polypeptides to treat, prevent, or reduce the progression rate and/or severity of post-capillary pulmonary hypertension (PcPH), particularly treating, preventing or reducing th...